dpp4 and glp-1 GLP 1 Receptor Agonists DPP 4 Inhibitors Mechanism of Action Neuroprotection by dipeptidyl-peptidase-4 inhibitors and

Below are observed minimum, median, and maximum annual funding levels per employee from our 2026 Annual Lifestyle Benefits Benchmark Report, based on 2025 program data

Huang, Hsin-Che

Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS)

When rheumatologists use them for inflammatory arthritis, it is considered off-label prescribing a legal and common practice when supported by emerging clinical evidence and individualized patient need

priority review is 6 months, possible given unmet need

References & Citations Graf MV, Kastin AJ